Randomized controlled trial for the efficacy of hepatic arterial occlusion during radiofrequency ablation for small hepatocellular carcinoma - Direct ablative effects and a long-term outcome

Liver International

Volumn 27, Issue 3, 2007, Pages 353-359

  Kobayashi, Masahiro ^a,b   Ikeda, Kenji ^a,b   Kawamura, Yusuke ^a,b   Hosaka, Tetsuya ^a,b   Sezaki, Hitomi ^a,b   Yatsuji, Hiromi ^a,b   Akuta, Norio ^a,b   Suzuki, Fumitaka ^a,b   Suzuki, Yoshiyuki ^a,b   Arase, Yasuji ^a,b   Kumada, Hiromitsu ^a,b  

^a TORANOMON HOSPITAL   (Japan)

^b Memorial Institute for Medical Research   (Japan)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Recurrence; Stepwise hook extension; Vascular occlusion

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BALLOON OCCLUSION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; HEPATIC ARTERY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MALE; OUTCOME ASSESSMENT; PLEURA EFFUSION; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TUMOR RECURRENCE; TUMOR VOLUME;

AGED; BALLOON OCCLUSION; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 33947282252     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01434.x     Document Type: Article

References (27)

1. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729-38.
2. Tang Z. Screening and early treatment of primary liver cancer: With special reference to the east part of China. Ann Acad Med 1980; 9: 237-9.
3. Health and Welfare Statistics Association. Health and Welfare Statistics. Tokyo: Journal of Health Welfare Statistics, 2000; 421.
4. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69: 925-9.
5. Lencioni R, Bartolozzi C, Caramella D, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer 1995; 72: 1737-46.
6. Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-61.
7. Shiina S, Takuma T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-30.
8. Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound-guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Intervent Radiol 1993; 8: 97-103.
9. Allgaier HP, Galandi D, Zuber I, et al. Radiofrequency thermal ablation of hepatocellular carcinoma. Dig Dis 2001; 19: 301-10.
10. Goldberg SN, Gazell S, Solbiati L, et al. Radiofrequency ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996; 3: 636-44.
11. Burdio F, Guemes A, Burdio JM, et al. Hepatic lesion ablation with bipolar saline-enhanced radiofrequency in the audible spectrum. Acad Radiol 1999; 6: 680-6.
12. Goldberg SN, Hahn PF, Halpern EF, et al. Radio-frequency tissue ablation: Effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 1998; 209: 761-7.
13. Lu DS, Raman SS, Vodopich DJ, et al. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: Assessment of the "heat sink" effect. AJR Am J Roentgenol 2002; 178: 47-51.
14. Patterson EJ, Scudamore CH, Owen DA, et al. Radiofrequency ablation of porcine liver in vivo: Effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227: 559-65.
15. Chang CK, Hendy MP, Smith JM, et al. Radiofrequency ablation of the porcine liver with complete hepatic vascular occlusion. Ann Surg Oncol 2002; 9: 594-8.
16. Chinn SB, Lee FT Jr, Kennedy GD, et al. Effect of vascular occlusion on radiofrequency ablation of the liver: Results in a porcine model. Am J Roentgenol 2001; 176: 789-95.
17. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: Does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9: 101-11.
18. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumour blood supply. Radiology 2000; 217: 119-26.
19. Yamasaki T, Kurokawa F, Shirahashi H, et al. Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma. Cancer 2001; 91: 1342-8.
20. de Baere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumours during temporary venous occlusion. Am J Roentgenol 2002; 178: 53-9.
21. Yamasaki T, Kimura T, Kurokawa F, et al. Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma. J Gastroenterol 2005; 40: 171-8.
22. Kobayashi M, Ikeda K, Someya T, et al. Stepwise hook extension technique for radiofrequency ablation therapy of hepatocellular carcinoma. Oncology 2002; 63: 139-44.
23. Kotoh K, Nakamuta M, Morizono S, et al. A multi-step, incremental expansion method for radiofrequency ablation: Optimization of the procedure to prevent increases in intra-tumour pressure and to reduce the ablation time. Liv Int 2005; 25: 542-7.
24. Vivalrelli M, Guglielmi A, Ruzzenente A, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240: 102-7.
25. Montorsi M, Santambrogio R, Bianchi P, et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: A multivariate analysis. J Gastrointest Surg 2005; 9: 62-8.
26. Hong SN, Lee SY, Choi MS, et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005; 39: 247-52.
27. Ikeda K, Kobayashi M, Saitoh S, et al. Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter. Hepatol Res 2005; 33: 241-9.